跳至主要内容
临床试验/NCT04834726
NCT04834726已完成不适用

Pragmatic Trial of COVID Vaccine Text Outreach Interventions

University of Pennsylvania1 个研究点 分布在 1 个国家目标入组 19,554 人开始时间: 2021年4月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
19,554
试验地点
1
主要终点
Dose 1 Completion

研究概览

简要总结

This project aims to evaluate different approaches to increase COVID-19 vaccine uptake among at-risk patients at Penn Medicine in an equitable and systematic manner through a centralized outreach program. The investigators will evaluate different text-based scheduling and messaging approaches informed by behavioral science to increase uptake among eligible patients, including the use of clinician endorsement, opt-out framing, and scarcity.

详细描述

This project will evaluate a centralized approach to increasing COVID through direct outreach to eligible patients via text messaging. This pragmatic randomized controlled trial has the following aims:

Aim 1: To conduct systematic large scale text message outreach for vaccine delivery among a defined group of Penn Medicine in a way that advances equity.

Aim 2: To offer different scheduling workflows through text messaging that might increase uptake and reduce disparities.

Aim 3: To compare the equity and efficiency of different messages informed by behavioral science, including PCP endorsement, opt-out framing, and scarcity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Health Services Research
盲法
Double (Participant, Investigator)

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patients of Penn Medicine aged 18+ who reside in Philadelphia and who have had at least 1 visit in the past 5 years with a Penn Medicine primary care provider (PCP)

排除标准

  • •Patients who have completed any dose of the vaccine at Penn Medicine, are currently scheduled to receive the vaccine, have externally documented vaccination records, or have previously received text-message based vaccine outreach.

研究组 & 干预措施

1: Usual Care

Active Comparator

Patients will receive a phone call to schedule their appointment from an Access Center representative. Access Center representatives will make up to 3 attempts to schedule an appointment with the patient. Patients randomized to this arm will not receive any text messaging.

干预措施: Phone Call (Behavioral)

2A: Call Back + Standard Msg

Experimental

The message describes that the patient is eligible for the COVID vaccine. Will include a prompt to agree to scheduling. The access center will call these patients back to schedule, calling up to 3 times.

干预措施: Opt-In (Call-Back) (Behavioral)

2D: Call Back + Opt-Out Framing

Experimental

The message will highlight that a vaccine is reserved for the patient, implying that they need to opt-outWill include a prompt to agree to scheduling. The access center will call these patients back to schedule, calling up to 3 times.

干预措施: Opt-In (Call-Back) (Behavioral)

2A: Call Back + Standard Msg

Experimental

The message describes that the patient is eligible for the COVID vaccine. Will include a prompt to agree to scheduling. The access center will call these patients back to schedule, calling up to 3 times.

干预措施: Standard Message (Behavioral)

2B: Call Back + Clinician Endorsement

Experimental

The message will describe an endorsement from the provider to get the vaccination. Will include a prompt to agree to scheduling. The access center will call these patients back to schedule, calling up to 3 times.

干预措施: Opt-In (Call-Back) (Behavioral)

2B: Call Back + Clinician Endorsement

Experimental

The message will describe an endorsement from the provider to get the vaccination. Will include a prompt to agree to scheduling. The access center will call these patients back to schedule, calling up to 3 times.

干预措施: Clinician Endorsement (Behavioral)

2C: Call Back + Scarcity

Experimental

The message will highlight the limited availability and the elevated priority for the patient to receive the vaccine at Penn Medicine. Will include a prompt to agree to scheduling. The access center will call these patients back to schedule, calling up to 3 times.

干预措施: Opt-In (Call-Back) (Behavioral)

2C: Call Back + Scarcity

Experimental

The message will highlight the limited availability and the elevated priority for the patient to receive the vaccine at Penn Medicine. Will include a prompt to agree to scheduling. The access center will call these patients back to schedule, calling up to 3 times.

干预措施: Scarcity (Behavioral)

2D: Call Back + Opt-Out Framing

Experimental

The message will highlight that a vaccine is reserved for the patient, implying that they need to opt-outWill include a prompt to agree to scheduling. The access center will call these patients back to schedule, calling up to 3 times.

干预措施: Opt-Out Framing (Behavioral)

3A: In-Bound Call + Standard Msg

Experimental

The message describes that the patient is eligible for the COVID vaccine. Will include a prompt to agree to scheduling, which will be followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.

干预措施: Opt-in (In-Bound) (Behavioral)

3A: In-Bound Call + Standard Msg

Experimental

The message describes that the patient is eligible for the COVID vaccine. Will include a prompt to agree to scheduling, which will be followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.

干预措施: Standard Message (Behavioral)

3B: In-Bound Call + Clinician Endorsement

Experimental

The message will describe an endorsement from the provider to get the vaccination. Will include a prompt to agree to scheduling, which will be followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.

干预措施: Opt-in (In-Bound) (Behavioral)

3B: In-Bound Call + Clinician Endorsement

Experimental

The message will describe an endorsement from the provider to get the vaccination. Will include a prompt to agree to scheduling, which will be followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.

干预措施: Clinician Endorsement (Behavioral)

3C: In-Bound Call + Scarcity

Experimental

The message will highlight the limited availability and the elevated priority for the patient to receive the vaccine at Penn Medicine. Will include a prompt to agree to scheduling, which will be followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.

干预措施: Opt-in (In-Bound) (Behavioral)

3C: In-Bound Call + Scarcity

Experimental

The message will highlight the limited availability and the elevated priority for the patient to receive the vaccine at Penn Medicine. Will include a prompt to agree to scheduling, which will be followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.

干预措施: Scarcity (Behavioral)

3D: In-Bound Call + Opt-Out Framing

Experimental

The message will highlight that a vaccine is reserved for the patient, implying that they need to opt-out. Will include a prompt to agree to scheduling, which will be followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.

干预措施: Opt-in (In-Bound) (Behavioral)

3D: In-Bound Call + Opt-Out Framing

Experimental

The message will highlight that a vaccine is reserved for the patient, implying that they need to opt-out. Will include a prompt to agree to scheduling, which will be followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.

干预措施: Opt-Out Framing (Behavioral)

结局指标

主要结局

Dose 1 Completion

时间窗: 1 month

Percentage of patients who complete the first dose of the COVID vaccine within 1 month of initial outreach

次要结局

  • Vaccine Completion(2 months)
  • Dose 1 Completion(2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shivan J Mehta

Principal Investigator

University of Pennsylvania

研究点 (1)

Loading locations...

相似试验

COVID-19 Vaccine Text Outreach | 临床试验